Prognostic Value of Cardiovascular Biomarkers in the Population

Franz‐Josef Neumann; Raphael Twerenbold; Jessica Weimann; Christie M. Ballantyne; Emelia Benjamin; Simona Costanzo; James A. de Lemos; Christopher R. deFilippi; Augusto Di Castelnuovo; Chiara Donfrancesco; Marcus Dörr; Kai M. Eggers; Gunnar Engström; Stephan B. Felix; Maurizio Ferrario; Ron T. Gansevoort; Simona Giampaoli; Vilmantas Giedraitis; Pär Hedberg; Licia Iacoviello; Torben Jørgensen; Frank Kee; Wolfgang Köenig; Kari Kuulasmaa; Joshua R. Lewis; Thiess Lorenz; Magnus Nakrem Lyngbakken; Christina Magnussen; Olle Melander; Matthias Nauck; Teemu Niiranen; Peter M. Nilsson; Michael Hecht Olsen; Torbjørn Omland; Viktor Oskarsson; Luigi Palmieri; Annette Peters; Richard L. Prince; Vazhma Qaderi; Ramachandran S. Vasan; Veikko Salomaa; Susana Sans; J. G. Smith; Stefan Söderberg; Barbara Thorand; Andrew Tonkin; H Tunstall-Pedoe; Giovanni Veronesi; Tetsu Watanabe; Masafumi Watanabe; Andreas M. Zeiher; Tanja Zeller; Stefan Blankenberg; Francisco Ojeda

doi:10.1001/jama.2024.5596

Abstract

1 min read

Cardiovascular biomarkers were strongly associated with fatal and nonfatal cardiovascular events and mortality. The addition of biomarkers to established risk factors led to only a small improvement in risk prediction metrics for atherosclerotic cardiovascular disease, but was more favorable for heart failure and mortality.

Related publications

Article2012

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress

Thomas J. Wang, Kai C. Wollert, Martin G. Larson, Erin Coglianese, Elizabeth L. McCabe, Susan Cheng, Jennifer E. Ho, Michael G. Fradley, Anahita Ghorbani, Vanessa Xanthakis, Tibor Kempf, Emelia Benjamin, Daniel Levy, Ramachandran S. Vasan, James L. Januzzi

Article2013

Multiple Inflammatory Biomarkers in Relation to Cardiovascular Events and Mortality in the Community

Renate B. Schnabel, Xiaoyan Yin, Martin G. Larson, Jennifer F. Yamamoto, João D. Fontes, Sekar Kathiresan, Jian Rong, Daniel Levy, John F. Keaney, Thomas J. Wang, Joanne M. Murabito, Ramachandran S. Vasan, Emelia Benjamin

Article2023

#4779 CARDIAC BIOMARKERS FOR THE PREDICTION OF INCIDENT MAJOR ADVERSE CARDIAC EVENTS IN PATIENTS STARTING HAEMODIALYSIS: A REAL-WORLD ANALYSIS

Garry McDowell, Louise Moore, Benjamin J. R. Buckley, Philip Austin, Professor Gregory Lip, Anirudh Rao

Article1998

Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population

Riitta Antikaínen, Pekka Jousilahti, Jaakko Tuomilehto

Journal of Hypertension

Article2024

163 Prediction of outcomes in patients with hypertension using clinical laboratory biomarkers - a real-world analysis using a global federated database

Elliot Mbeta, Rajiv Sankaranarayanan, Philip Austin, Peter E. Penson, Professor Gregory Lip, Garry McDowell